Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ZYDUSLIFE Zydus Lifesciences Limited Pharma · Large | SUNPHARMA Sun Pharmaceutical Industries Limited Pharma · Large | GLENMARK Glenmark Pharmaceuticals Limited Pharma · Mid | AUROPHARMA Aurobindo Pharma Limited Pharma · Mid |
|---|---|---|---|---|
| Final Score | 63 | 48 | 65 | 38 |
| Verdict | UNDERVALUED | FAIR VALUE | UNDERVALUED | WATCHLIST |
| Style | Growth at Value | Financial Turnaround | Premium Compounder | WATCHLIST |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 12/30 | 4/30 | 1/30 | 7/30 |
| Growth | 21/25 | 14/25 | 23/25 | 8/25 |
| Quality | 12/20 | 11/20 | 20/20 | 0/20 |
| Balance Sheet | 10/15 | 10/15 | 10/15 | 11/15 |
| Cash Flow | 4/10 | 4/10 | 6/10 | 7/10 |
| Price | ₹1,103.4 | ₹1,779 | ₹2,209.6 | ₹1,440 |
| P/E | 20.20 | 34.40 | 20.80 | 23.80 |
| P/B | 4.04 | 5.14 | 5.85 | 2.23 |
| ROE | 21.20% | 16.00% | 30.50% | 10.10% |
| ROCE | 21.20% | 20.50% | 39.80% | 12.80% |
| Debt / Equity | 0.46 | 0.06 | 0.06 | 0.21 |
| FCF Yield | — | 0.25% | 3.52% | 4.34% |
| Dividend Y | 0.09% | 0.89% | 0.11% | 0.28% |
| Altman Z | 4.56 | 8.42 | 6.46 | 4.55 |
| Promoter % | 75.00% | 54.48% | 46.65% | 51.82% |
| Mkt Cap (₹Cr) | 109448.00 | 429193.00 | 61421.00 | 84306.00 |
| Graham # | ₹550.61 | ₹612.04 | ₹635.56 | ₹940.84 |
| Fair PE | 42.0 | 42.0 | 42.0 | 8.7 |
| MoS % | +47.5% | +11.4% | -9.0% | -173.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startZYDUSLIFE114
SUNPHARMA98
GLENMARK133
AUROPHARMA109